Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Ajanta Pharma Financial Results

Ajanta Pharma Ltd reported its FY 2026 financial results, with annual consolidated revenue crossing ₹5,453 Crore and PAT exceeding ₹1,056 Crore. The company achieved 21% quarterly revenue growth and 18% PAT growth. Branded generics across India, Asia, and Africa remains the core business, contributing 68% of total revenue.

Source

BSE filing, NSE: AJANTPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Ajanta Pharma Ltd: key numbers

Share price
₹3,508.80
Market cap
₹43,846 Cr
Revenue (annual)
₹5,453 Cr
Net profit (annual)
₹1,056 Cr
P/E (TTM)
34.7×Sector 45.9×
Promoter holding
63.47%-0.01% QoQ
FII holding
7.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Ajanta Pharma Ltd

All →
12:55 IST BSE
Financial Results

Ajanta Pharma Q2 FY27 Results: Net Profit ₹388.1 Cr, Up 49.2% YoY

Ajanta Pharma Ltd reported revenue from operations of ₹1,794 Cr (+32.5% YoY) and net profit of ₹388.1 Cr (+49.2% YoY) for Q2 FY27.

Key figure
Net profit ₹388.1 Cr · +49.2% YoY

Other financial results announcements

All →
21:34 IST BSE
Financial ResultsChemkart India Ltd 544442

Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY

Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.

Key figure
Net profit ₹22.6 Cr · +121.6% YoY